| A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors (NCT05781386) | Jiangsu Simcere Biologics Co., Ltd | 2022-03-06 |
| PRP for the Treatment of Erectile Dysfunction (ED) (NCT04350125) | Mayo Clinic | 2022-03-04 |
| A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis (NCT05089409) | AmtixBio Co., Ltd. | 2022-03-04 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. (NCT05333419) | PolyActiva Pty Ltd | 2022-03-04 |
| A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN) (NCT05027204) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-03-04 |
| Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes (NCT05038592) | M.D. Anderson Cancer Center | 2022-03-04 |
| FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer (NCT05304962) | Regor Pharmaceuticals Inc. | 2022-03-04 |
| Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers (NCT04645160) | National Cancer Institute (NCI) | 2022-03-04 |
| Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers (NCT05314933) | G.ST Antivirals GmbH | 2022-03-03 |
| A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump (NCT05262595) | Novo Nordisk A/S | 2022-03-03 |
| A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514 (NCT05264038) | Oncocross Australia Pty Ltd. | 2022-03-03 |
| A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab (NCT05068102) | Boehringer Ingelheim | 2022-03-03 |
| Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant (NCT05553470) | Corcept Therapeutics | 2022-03-03 |
| Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought (NCT05301608) | Johns Hopkins University | 2022-03-03 |
| FRDA Investigator Initiated Study (IIS) With Elamipretide (NCT05168774) | Children's Hospital of Philadelphia | 2022-03-03 |
| COAST Therapy in Advanced Solid Tumors and Prostate Cancer (NCT05036226) | Medical University of South Carolina | 2022-03-03 |
| A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity (NCT05254158) | Novo Nordisk A/S | 2022-03-03 |
| Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (NCT05364021) | Longboard Pharmaceuticals | 2022-03-03 |
| Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation (NCT05263895) | Pfizer | 2022-03-03 |
| A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors (NCT05205850) | RemeGen Co., Ltd. | 2022-03-03 |
| Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia (NCT05444413) | Affiliated Hospital of Nantong University | 2022-03-03 |
| Clinical Trial on Pharmacokinetics and Tolerability of AP707 (NCT05267769) | CannaXan GmbH | 2022-03-02 |
| huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer (NCT05057715) | University of Pennsylvania | 2022-03-02 |
| A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05354362) | Antengene Corporation | 2022-03-02 |
| Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors (NCT05220722) | TriSalus Life Sciences, Inc. | 2022-03-02 |
| First in Human Study of M1069 in Advanced Solid Tumors (NCT05198349) | EMD Serono Research & Development Institute, Inc. | 2022-03-02 |
| Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants (NCT05265247) | HALEON | 2022-03-02 |
| Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) (NCT05435248) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-03-02 |
| Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease (NCT05361382) | Tharick Pascoal | 2022-03-02 |
| A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. (NCT06356389) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2022-03-02 |
| Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer (NCT04701281) | AllVascular | 2022-03-02 |
| A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS) (NCT06768658) | Takeda | 2022-03-02 |
| ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (NCT05082259) | Institute of Cancer Research, United Kingdom | 2022-03-02 |
| Fruquintinib DDI Study With P-gp and BCRP Substrates (NCT05368805) | Hutchmed | 2022-03-02 |
| Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor Necrotic Factor α Level (NCT05288920) | Beni-Suef University | 2022-03-01 |
| Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma (NCT05439993) | Hallym University Medical Center | 2022-03-01 |
| Treatment of Alopecia Using Follicular Stem Cells (NCT05210452) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors (NCT05172856) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-03-01 |
| A Dose-finding Trial of Hyperthermic Intraperitoneal Docetaxel (NCT05410483) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-03-01 |
| A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants (NCT05271799) | GlaxoSmithKline | 2022-03-01 |
| A Study of JNJ-70075200 in Healthy Participants (NCT04782661) | Janssen Research & Development, LLC | 2022-03-01 |
| Dexamedtomidine in Control of Intracranial Pressure in Preeclampsia (NCT05119101) | Assiut University | 2022-03-01 |
| Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers (NCT07450833) | Benfovir AG | 2022-03-01 |
| Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries (NCT05245721) | Assiut University | 2022-03-01 |
| Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation (NCT05250362) | Sichuan University | 2022-03-01 |
| Detection of Cannabis Impairment With ISBRG's SpotLight-THC (NCT05276232) | ISBRG Corp | 2022-03-01 |
| Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor (NCT05862714) | Combined Military Hospital Abbottabad | 2022-03-01 |
| A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury (NCT05114226) | West China Second University Hospital | 2022-03-01 |
| A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome (NCT05282446) | Inversago Pharma Inc. | 2022-03-01 |
| Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil (NCT04959812) | University of Texas Southwestern Medical Center | 2022-03-01 |
| Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum (NCT05634460) | Combined Military Hospital Abbottabad | 2022-03-01 |
| Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors (NCT05235607) | Sichuan University | 2022-03-01 |
| A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors (NCT05234606) | Silverback Therapeutics | 2022-03-01 |
| Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts (NCT05588999) | Combined Military Hospital Abbottabad | 2022-03-01 |
| Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease (NCT05039411) | CryoCord Sdn Bhd | 2022-03-01 |
| Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells (NCT05167552) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients (NCT05258565) | Assiut University | 2022-03-01 |
| Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis (NCT05225805) | Nabriva Therapeutics AG | 2022-03-01 |
| Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies (NCT05862701) | Combined Military Hospital Abbottabad | 2022-03-01 |
| A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion (NCT04548843) | Minovia Therapeutics Ltd. | 2022-03-01 |
| Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder (NCT04880278) | New York State Psychiatric Institute | 2022-03-01 |
| Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) (NCT03769688) | Johns Hopkins University | 2022-03-01 |
| Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells (NCT05186883) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss (NCT05237843) | Ain Shams University | 2022-03-01 |
| Stromal Vascular Fraction (SVF) Therapy in Patients With Acute Spontaneous Intracerebral Hemorrhage (SICH). (NCT05232903) | Beijing Tiantan Hospital | 2022-03-01 |
| A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. (NCT05598268) | ImmVira Pharma Co. Ltd | 2022-03-01 |
| Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis (NCT05578950) | Combined Military Hospital Abbottabad | 2022-03-01 |
| Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT (NCT05275699) | Peking Union Medical College Hospital | 2022-03-01 |
| Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis (NCT05643820) | Combined Military Hospital Abbottabad | 2022-03-01 |
| Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells (NCT05187104) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells (NCT05207995) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants (NCT04041674) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-01 |
| Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis (NCT05136560) | CHA University | 2022-03-01 |
| Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells (NCT05108077) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors (NCT05238818) | XinWu | 2022-03-01 |
| Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL (NCT05238064) | Fudan University | 2022-03-01 |
| An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma (NCT05251948) | Hoffmann-La Roche | 2022-03-01 |
| A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma (NCT05185531) | Shandong Cancer Hospital and Institute | 2022-03-01 |
| 131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma (NCT05063357) | Y-mAbs Therapeutics | 2022-03-01 |
| A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva (NCT05299073) | mAbxience Research S.L. | 2022-03-01 |
| First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383 (NCT05429723) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-03-01 |
| Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML (NCT05584761) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-01 |
| Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia (NCT04961801) | Shin Mineishi | 2022-03-01 |
| Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film (NCT05328414) | Deraya University | 2022-03-01 |
| A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) (NCT04988555) | Sumitomo Pharma America, Inc. | 2022-02-28 |
| Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients (NCT05109650) | Bio-Thera Solutions | 2022-02-28 |
| Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects (NCT05272683) | Lakefront Biotherapeutics NV | 2022-02-28 |
| Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma (NCT05004025) | HonorHealth Research Institute | 2022-02-28 |
| A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) (NCT05262413) | Qilu Pharmaceutical Co., Ltd. | 2022-02-28 |
| CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects (NCT05238948) | Chong Kun Dang Pharmaceutical | 2022-02-28 |
| Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy (NCT05044039) | Washington University School of Medicine | 2022-02-28 |
| Human Immune Response to Ixodes Scapularis Tick Bites (NCT05036707) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-28 |
| A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants (NCT05257798) | Pfizer | 2022-02-28 |
| Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL (NCT05259813) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2022-02-28 |
| Single Ascending Dose Study of ANX105 (NCT05288881) | Annexon, Inc. | 2022-02-28 |
| Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) (NCT05435027) | Gritstone bio, Inc. | 2022-02-28 |
| Phase 1 First-in-human Study of JS014 (NCT05296772) | Anwita Biosciences | 2022-02-28 |
| Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy (NCT05251376) | Lyndra Inc. | 2022-02-28 |
| A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects (NCT05196711) | Maxinovel Pty., Ltd. | 2022-02-28 |